AVMs are often detected incidentally or following neurological symptoms such as seizures. While rupture can lead to life-threatening bleeding, treatment decisions have long been hampered by uncertainty over the natural risk of bleeding in unruptured cases.
The MARS project combined data from 2 population-based and 7 referral-based cohorts, making it one of the largest analyses of its kind. The study included a total of the 3,030 participants with unruptured brain AVMs (median age 38 years; 50.3% female). Nearly half of the patients (45%) presented with seizures at diagnosis, and the median AVM size was about 3.1 cm.
Detailed angiographic assessments revealed that 10% of AVMs had exclusively deep venous drainage, 11% were located in cerebellar or supratentorial deep regions, and 19% had associated arterial aneurysms that can increase bleeding risk.
During the follow-up period totaling 11,339 person-years, 159 first hemorrhages were recorded, which resulted in the revised ICH rate of 1.4 per 100 person-years (95% CI, 1.20–1.64). This research then identified several key independent risk factors that increase the risk of a first hemorrhage.
Age emerged as a significant variable, with patients over 60 years old showing a more than 2-fold higher risk (hazard ratio [HR], 2.01) when compared to those younger than 20. Middle-aged groups (40–59 years) had a moderate risk increase (HR, 1.23), while those aged 20–39 showed slightly reduced risk when compared to the youngest patients.
The presence of associated arterial aneurysms raised the bleeding risk by 66% (HR, 1.66), while AVMs located in deep or cerebellar brain regions nearly doubled the risk (HR, 1.87) relative to more superficial sites. Overall, this study highlights the importance of personalized management strategies which balances the modest annual bleeding risk against the potential complications of surgical or endovascular interventions.
Reference:
Kim, H., Nelson, J., McCulloch, C. E., Hess, C., Hetts, S. W., Flemming, K., Lanzino, G. S., 2nd, Koroknay-Pál, P., Oulasvirta, E., Laakso, A., Lawton, M. T., Mohr, J. P., Morgan, M. K., Moayeri, N., Zaroff, J. G., Stefani, M. A., Chen, X., Zhao, Y., & Al-Shahi Salman, R. (2025). Risk of future hemorrhage from unruptured brain arteriovenous malformations: The Multicenter Arteriovenous Malformation Research Study (MARS): The multicenter arteriovenous malformation research study (MARS). JAMA Neurology. https://doi.org/10.1001/jamaneurol.2025.3581
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.